ArticleHuman vaccines & immunotherapeutics2024

Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China.

Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.